Citi raised the firm’s price target on AbbVie (ABBV) to $215 from $170 and keeps a Buy rating on the shares following a transfer of ...

Through a partnership, a third Waco ISD school will receive a new STEM lab for students to get hands-on experience.

Acute Migraine Treatment MarketThe global migraine treatment market is anticipated to achieve a valuation of USD 3.2 billion ...

Investor focus will likely be on the sales performance of ABBV's blockbuster immunology drugs, Rinvoq and Skyrizi, when it ...

AbbVie Inc. (NYSE:ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. It is set to report its Q3 ...

On Thursday, AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $189.65 which represents a slight increase of $1.77 or 0.94% from the prior close of $187.88. The stock opened at $188.43 ...

Dividend stocks can be valuable investments for retirees who want a consistent stream of income flowing into their portfolio ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

Argent Capital Management LLC reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 96.3% in the 3rd quarter, ...

NORTH CHICAGO, IL, USA and BUDAPEST, Hungary I4, 2024 I AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, ...

AbbVie has entered a collaboration with Hungary-based pharmaceutical company Gedeon Richter to develop new treatments for ...

Half a million people across the UK, of whom I am one, live day in day out with Inflammatory Bowel Disease (IBD). IBD is a ...